AVTX
#2650
Avalo Therapeutics, Inc. - Common Stock
12.7 0 USD
-0.04%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-4.08%
Changement Mensuel
-22.70%
Evolution sur 6 mois
-6.34%
Changement Annuel
-6.55%
Clôture Précédente
13.2 4
Open
13.2 3
Low
12.5 4
High
13.2 3
Financials
2017
Current report, 17 Nov 2017
Avalo Therapeutics, Inc. current report, 17 November 2017
8-K
Current report, 06 Nov 2017
Avalo Therapeutics, Inc. current report, 06 November 2017
8-K
Current report, 20 Oct 2017
Avalo Therapeutics, Inc. current report, 20 October 2017
8-K
Quarterly report, Q3 FY2017
Avalo Therapeutics, Inc. quarterly report, Q3 FY2017
10-Q
Current report, 09 Aug 2017
Avalo Therapeutics, Inc. current report, 09 August 2017
8-K
Current report, 07 Jul 2017
Avalo Therapeutics, Inc. current report, 07 July 2017
8-K
Quarterly report, Q2 FY2017
Avalo Therapeutics, Inc. quarterly report, Q2 FY2017
10-Q
Current report, 09 Jun 2017
Avalo Therapeutics, Inc. current report, 09 June 2017
8-K
Current report, 12 May 2017
Avalo Therapeutics, Inc. current report, 12 May 2017
8-K
Current report, 09 May 2017
Avalo Therapeutics, Inc. current report, 09 May 2017
8-K